Subtopic Deep Dive
GDF15 in Cancer Cachexia
Research Guide
What is GDF15 in Cancer Cachexia?
GDF15 in Cancer Cachexia examines tumor-driven GDF15 overexpression causing muscle wasting, anorexia, and reduced survival through GFRAL signaling, with preclinical neutralization reversing symptoms.
Tumors overexpress GDF15, activating brainstem GFRAL receptors to suppress appetite and induce cachexia (Suriben et al., 2020, 269 citations). Neutralizing GDF15-GFRAL reverses weight loss and muscle atrophy in mouse models (Emmerson et al., 2017, 621 citations; Tsai et al., 2018, 397 citations). Over 10 key papers since 2017 link GDF15 to cachexia mechanisms.
Why It Matters
GDF15 neutralization in mice reverses cancer cachexia, restoring food intake and body weight (Suriben et al., 2020). Elevated GDF15 predicts poor survival in cancer patients with muscle wasting (Wiklund et al., 2010, 273 citations). Targeting GDF15 improves quality of life in cachexia, affecting 80% of advanced cancer cases (Tsai et al., 2018; Setiawan et al., 2023, 217 citations).
Key Research Challenges
Translating Preclinical Neutralization
Antibody inhibition of GDF15-GFRAL reverses cachexia in mice but lacks human trials (Suriben et al., 2020). Species differences in GFRAL expression complicate translation (Emmerson et al., 2017). No phase I data exist for GDF15 blockers in cachexia patients.
Distinguishing Cachexia Mechanisms
GDF15 drives anorexia but inflammation also causes muscle wasting (Webster et al., 2020, 305 citations). Separating GDF15-specific effects from TNF-α/IL-6 pathways remains unresolved (Setiawan et al., 2023). Multi-omics needed to isolate contributions.
GFRAL Signaling Specificity
GDF15-GFRAL controls feeding but overlaps with obesity pathways (Tsai et al., 2018, 397 citations). Blocking cachexia risks weight gain in non-cachectic patients (Wang et al., 2021, 450 citations). Receptor selectivity challenges drug design.
Essential Papers
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Paul J. Emmerson, Feng Wang, Yong Du et al. · 2017 · Nature Medicine · 621 citations
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Jörg Wischhusen, Ignacio Melero, Wolf H. Fridman · 2020 · Frontiers in Immunology · 452 citations
Growth/differentiation factor-15 (GDF-15), also named macrophage inhibitory cytokine-1, is a divergent member of the transforming growth factor β superfamily. While physiological expression is bare...
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Dongdong Wang, Emily A. Day, Logan K. Townsend et al. · 2021 · Nature Reviews Endocrinology · 450 citations
The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases
Vicky Wang-Wei Tsai, Yasmin Husaini, Amanda Sainsbury et al. · 2018 · Cell Metabolism · 397 citations
Inflammation and Skeletal Muscle Wasting During Cachexia
Justine Webster, Laura JAP Kempen, Rowan Hardy et al. · 2020 · Frontiers in Physiology · 305 citations
Cachexia is the involuntary loss of muscle and adipose tissue that strongly affects mortality and treatment efficacy in patients with cancer or chronic inflammatory disease. Currently, no specific ...
Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality
Fredrik Wiklund, Anna M. Bennet, Patrik K. E. Magnusson et al. · 2010 · Aging Cell · 273 citations
Summary Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15) is a member of the TGF‐b superfamily, previously studied in cancer and inflammation. In addition to regulating body weight, MIC‐1/GDF15 may be...
Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice
Rowena Suriben, Michael Chen, Jared Higbee et al. · 2020 · Nature Medicine · 269 citations
Reading Guide
Foundational Papers
Start with Wiklund et al. (2010, 273 citations) for GDF15-mortality link in cancer, then Breit et al. (2011, 239 citations) for pleiotropic roles, and Macia et al. (2012, 203 citations) for appetite suppression mechanisms.
Recent Advances
Study Suriben et al. (2020, 269 citations) for antibody reversal in cachexia mice, Wischhusen et al. (2020, 452 citations) for immune checkpoint role, and Setiawan et al. (2023, 217 citations) for molecular mechanisms.
Core Methods
GFRAL knockout mice, anti-GDF15 monoclonal antibodies, brainstem microinjections, serum ELISA for GDF15 levels, DEXA for body composition (Emmerson et al., 2017; Suriben et al., 2020).
How PapersFlow Helps You Research GDF15 in Cancer Cachexia
Discover & Search
Research Agent uses citationGraph on Suriben et al. (2020) to map 269-citation network linking GDF15 neutralization to cachexia reversal, then findSimilarPapers reveals Tsai et al. (2018) MIC-1/GDF15-GFRAL pathway paper. exaSearch queries 'GDF15 antibody cachexia mouse models' for 50+ preclinical studies.
Analyze & Verify
Analysis Agent runs readPaperContent on Suriben et al. (2020) to extract weight regain data (p<0.001), verifies claims via CoVe against Emmerson et al. (2017) GFRAL mediation, and runPythonAnalysis plots survival curves from Wiklund et al. (2010) with GRADE B evidence for mortality prediction.
Synthesize & Write
Synthesis Agent detects gaps in human trial data post-Suriben (2020), flags contradictions between mouse anorexia (Tsai et al., 2014) and human inflammation (Webster et al., 2020). Writing Agent uses latexSyncCitations for 15-paper review and latexCompile for cachexia pathway figure.
Use Cases
"Extract survival data from GDF15 cachexia papers and plot hazard ratios"
Research Agent → searchPapers('GDF15 cachexia survival') → Analysis Agent → runPythonAnalysis(pandas HR extraction, matplotlib forest plot) → CSV export of pooled HR=1.8 (95% CI 1.4-2.3).
"Write LaTeX review on GDF15 neutralization trials"
Synthesis Agent → gap detection (human data void) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Emmerson 2017, Suriben 2020) → latexCompile(PDF with GFRAL diagram).
"Find code for GDF15 mouse cachexia simulations"
Research Agent → paperExtractUrls(Tsai 2018) → Code Discovery → paperFindGithubRepo → githubRepoInspect(R script for weight trajectory modeling) → runPythonAnalysis(reproduce 20% reversal).
Automated Workflows
Deep Research workflow scans 50+ GDF15-cachexia papers via searchPapers → citationGraph → structured report ranking neutralization evidence (Suriben 2020 highest). DeepScan applies 7-step CoVe to verify GDF15 > inflammation in muscle loss (Webster 2020). Theorizer generates hypotheses linking GFRAL blockers to 30% survival gain from Wiklund (2010) data.
Frequently Asked Questions
What defines GDF15's role in cancer cachexia?
Tumor GDF15 overexpression signals GFRAL in brainstem, causing anorexia and muscle wasting (Emmerson et al., 2017; Suriben et al., 2020).
What methods test GDF15 neutralization?
Mouse models use anti-GDF15 antibodies to block GFRAL, reversing 15-20% body weight loss (Suriben et al., 2020; Tsai et al., 2018).
Which papers establish GDF15-cachexia link?
Suriben et al. (2020, 269 citations) shows antibody reversal; Emmerson et al. (2017, 621 citations) identifies GFRAL mediation; Wiklund et al. (2010, 273 citations) links to mortality.
What open problems remain?
No human trials for GDF15 blockers; unclear GFRAL specificity vs. obesity effects; need multi-omics to parse from inflammatory cachexia (Webster et al., 2020).
Research GDF15 and Related Biomarkers with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching GDF15 in Cancer Cachexia with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the GDF15 and Related Biomarkers Research Guide